PartsTable TECHNICAL DATA SHEET
NSN 6505-01-259-1553Government record, cited

Glyburide Tablets6505-01-259-1553

NSN 6505-01-259-1553 · NIIN 012591553
FSC 6505 — Drugs and Biologicals · FSG 65 — Medical, Dental, and Veterinary Equipment
Government record, cited
Also searched as  6505-01-259-1553 · 6505012591553 · NIIN 012591553 · 01-259-1553 · FSC 6505 Drugs and Biologicals · DIABETA TABLETS · NDC00039-0052-03
Nearby stock numbers  ·
Features
  • Glyburide Tablets — FSC 6505
  • Therapeutic Equivalent: DIABETA BY HOECHST-ROUSSEL PHARM.,INC.
  • Administration: ORAL
  • Primary Container Content Quantity: 30.000 TABLETS
  • Medical Designation and Grade: UNITED STATES PHARMACOPEIA
  • Features Provided: CHILD RESISTANT CLOSURE
  • Primary Container Type: BOTTLE
  • Active Medicament Medicinal Strength: 5.000 MILLIGRAMS GLYBURIDE ACTIVE INGREDIENT
Identification
  • NSN: 6505-01-259-1553
  • NIIN: 012591553
  • FSC: 6505 — Drugs and Biologicals
  • FSG: 65 — Medical, Dental, and Veterinary Equipment
General Description

The Glyburide Tablets, cataloged under National Stock Number 6505-01-259-1553, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 7 specifications, cited from the U.S. Government catalog. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.

Technical Specifications
ParameterValue
NSN6505-01-259-1553
Item NameGlyburide Tablets
FSC / FSG6505 / 65 — Drugs and Biologicals
StatusACTIVE
Therapeutic EquivalentDIABETA BY HOECHST-ROUSSEL PHARM.,INC.
AdministrationORAL
Primary Container Content Quantity30.000 TABLETS
Medical Designation and GradeUNITED STATES PHARMACOPEIA
Features ProvidedCHILD RESISTANT CLOSURE
Primary Container TypeBOTTLE
Active Medicament Medicinal Strength5.000 MILLIGRAMS GLYBURIDE ACTIVE INGREDIENT
Lifecycle & Compliance
Acquisition StatusACTIVE
DEMIL CodeDEMIL A — No Demilitarization Required
HazardPossible hazard — SDS may be required (DLA HMIC P)
Criticality CodeX
Unit of IssueBT
Cross-Reference Index
No manufacturer part numbers on file in the U.S. Government catalog.
Reference documents
ReferenceMeaning
DIABETA TABLETS 5/9 Secondary reference
Hoechst-Roussel Pharmaceuticals Inc
NDC00039-0052-03 3/9 Design control — primary reference
Hoechst-Roussel Pharmaceuticals Inc

Frequently Asked Questions

What is NSN 6505-01-259-1553?

NSN 6505-01-259-1553 is a Glyburide Tablets, classified under FSC 6505, Drugs and Biologicals. Status: active.

What are the specifications of 6505-01-259-1553?

Key specifications for 6505-01-259-1553: Therapeutic Equivalent: DIABETA BY HOECHST-ROUSSEL PHARM.,INC.; Administration: ORAL; Primary Container Content Quantity: 30.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA. 7 specifications are documented in the U.S. Government catalog.

Is NSN 6505-01-259-1553 hazardous material?

Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.

Sources

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.

✓ Data cited from the U.S. Government catalog; commercial cross-references from OEM and certified industry sources.
PartsTable Design LLC · partstable.com